mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0007 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |